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Most of human genome is present in two copies (maternal and paternal). However, segments of the genome can be
deleted or duplicated, and many of these genomic variations (known as Copy Number Variants) are associated
with psychiatric disorders. 16p11.2 copy number variants (breakpoint 4–5) confer high risk for neuro-
developmental disorders and are associated with structural brain alterations of large effect-size. Methods used in
previous studies were unable to investigate the onset of these alterations and whether they evolve with age. In this
study, we aim at characterizing age-related effects of 16p11.2 copy number variants by analyzing a group with a
broad age range including younger individuals. A large normative developmental dataset was used to accurately
adjust for effects of age. We normalized volumes of segmented brain regions as well as volumes of each voxel
defined by tensor-based morphometry. Results show that the total intracranial volumes, the global gray and white
matter volumes are respectively higher and lower in deletion and duplication carriers compared to control
subjects at 4.5 years of age. These differences remain stable through childhood, adolescence and adulthood until
23 years of age (range: 0.5 to 1.0 Z-score). Voxel-based results are consistent with previous findings in 16p11.2
copy number variant carriers, including increased volume in the calcarine cortex and insula in deletions,
compared to controls, with an inverse effect in duplication carriers (1.0 Z-score). All large effect-size voxel-based
differences are present at 4.5 years and seem to remain stable until the age of 23. Our results highlight the
stability of a neuroimaging endophenotype over 2 decades during which neurodevelopmental symptoms evolve at
a rapid pace.1. Introduction
Most of human genome is present in two copies (a maternal and
paternal copy). However, large segments of the genome can be deleted or
duplicated and are therefore present in one or three copies respectively.esearch Center, 3175 Chemin de
al.ca (S. Jacquemont).
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m 23 August 2019; Accepted 2 SWhile these genomic variations (known as Copy Number Variants, CNVs)
can often be harmless, many have also been associated with neuro-
developmental and psychiatric disorders. The ~600 kb 16p11.2 CNVs
(chromosome 16, locus 11.2, breakpoints (BP) 4–5, 29.6–30.2Mb-Hg19)
are strongly associated with neurodevelopmental disorders (Weiss et al.,la Co^te-Sainte-Catherine, Montreal, Quebec, H3T 1C5, Canada.
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Table 1
Population characteristics of the 16p11.2 dataset.
DEL CTRL DUP








range (min-max) 6.33-22.33 4.67-22.92 5–20.33
Sex (M/F) 29/27 67/38 13/6




Mean (SD) 87 (14)b 108 (12) 77 (19)b
Ancestry
African-American 0 12 0
Asian 1 1 0
Caucasian 50 35 15
Mixed and Other 4 8 2
DEL, deletion carriers; CTRL, control individuals; DUP, duplication carriers; N,
sample size; SD, standard deviation; M, male; F, female; NVIQ, non-verbal
intelligent quotient. Ancestry is unknown for 3 CNV carriers and 49 controls.
a Deletion carriers significantly younger than control individuals (t¼4.5272,
p¼ 1.347e-05).
b Mean NVIQ is significantly lower in deletion and duplication carriers than
control individuals (respectively t¼9.3194, p¼ 1.0126e-14; t¼6.6931,
p¼ 4.18997e-06).
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developing autism spectrum disorders (ASD) (Moreno-De-Luca et al.,
2013), and duplication (but not deletion) carriers a 10-fold increased risk
for schizophrenia (Marshall et al., 2017). Genetic variants associated
with psychiatric disorders offer unique opportunity to study the effects of
the same molecular mechanisms on brain structure and behavior across
different neurodevelopmental periods.
Deletion and duplications at the 16p11.2 locus have “mirror” effects
on head circumference, increasing and decreasing respectively with
differences becoming apparent before two years of age (D'Angelo et al.,
2016). At the macroscopic level, total gray and white matter volumes
correlate negatively with the number of genomic copies (Benjamini and
Hochberg, 1995; Qureshi et al., 2014; Maillard et al., 2015), with
increased volume in deletion and volume loss in duplication carriers
when compared to non-carriers. Previous studies in deletion carriers
report regional structural differences in the insula, calcarine cortex and
superior, middle, transverse temporal gyri, which are independent of
head size alterations. Duplication carriers show differences in the insula,
caudate and hippocampus (Martin-Brevet et al., 2018). These findings
are observed independently of sex and ascertainment (ie. the presence or
absence of a psychiatric diagnosis). Alterations are present in adolescents
as well as in adults. In the absence of proper normative data we have been
unable to accurately adjust for age effects. It is unknown when these
alterations appear during brain development or whether they are
modified across childhood and adolescence.
Given that genes included in the 16p11.2 interval are expressed
throughout early brain development (Lin et al., 2015), we hypothesized
that the established pattern of brain alterations associated with 16p11.2
CNVs might appear during early childhood. We aimed to characterize
brain growth in 16p11.2 CNVs carriers by comparing global and regional
developmental trajectories to those of healthy children. Considering the
fact that most of the brain measures do not show linear changes across
childhood and adolescence (Giedd et al., 1999), we assume that it is very
difficult, if not impossible, to properly correct for age based on small
control groups. Instead, large normative developmental datasets are
required to infer these trajectories. We (Aubert-Broche et al., 2013) have
previously developed a longitudinal image processing pipeline and
Z-scoring method to adjust for age- and sex effects on brain growth tra-
jectories using the NIH MRI study of normal brain development (NIHPD)
(Evans and Brain Development Cooperative, 2006). This normalizing
method extended to whole-brain voxel-level data, where all Jacobian
determinants of a deformation field were used as a surrogate metric of
relative local tissue volume. This approach has been successful in the
study of pediatric-onset multiple sclerosis (Aubert-Broche et al., 2014). In
the present study, we use similar methods to Z-score a cross-sectional
16p11.2 dataset (56 deletion carriers, 19 duplication carriers, 105 con-
trol individuals, including data on 8 individuals not analyzed in previous
studies) to identify global and voxel-based differences between groups.
2. Material and methods
2.1. Participants
2.1.1. 16p11.2 CNVs cohort
Cross-sectional data was acquired in 2 different cohorts (the European
-EU 16p11.2 consortium and the Simons VIP -SVIP study in North
America) of 180 individuals (Simons Vip, 2012; Martin-Brevet et al.,
2018). In order to be able to normalize with NIHPD data, we only
included participants between 4.5 and 23 years of age. This included 56
16p11.2 BP4-5 deletion carriers (DEL) from American (n¼ 42) and Eu-
ropean (¼14) cohorts; 19 duplication carriers (DUP) from American
(n¼ 15) and European (n¼ 4) cohorts); and 105 controls (CTRL), from
American (n¼ 75) and European cohorts (n¼ 30). Four controls, 3
duplication and 1 deletion carriers were not included in our previous
publication (Martin-Brevet et al., 2018). CNV carriers were either pro-
bands referred for genetic testing or relatives of probands. The controls2were recruited among non-carriers first-degree relatives of CNV carriers
(n¼ 34) or volunteers from the general population who did not have a
relative with a neurodevelopmental disorder (n¼ 71). The study was
approved by the institutional review boards of each consortium, and
signed informed consents were obtained from the participants or their
legal representatives. Demographics, age distribution and neuropsychi-
atric diagnoses are detailed in Table 1, Supplementary Fig. 1, Supple-
mentary Table 1. Because our analysis covers a broad age range, there is
increased risk of systematic age-dependent motion artefacts. We per-
formed a thorough visual quality control check looking for evidence of
motion artefacts.
2.1.2. General population – NIHPD cohort
As normative reference data for brain growth, we used the multi-site
longitudinal data from Objective 1 (i.e. initial time-point for enrolment
from 4.5 to 18.5 years) of the publicly available NIHPD project (Evans
and Brain Development Cooperative, 2006). The normative model
(Aubert-Broche et al., 2011) used data from 339 children (179 females
and 160 males), scanned longitudinally at 2 or 3 time points, with
approximately 24 months between scans and mean age at first scan of
11.0 years, for a total of 874 scans. Only subjects that passed quality
control were included. Supplementary Fig. 2 shows the age distribution
of the data for the NIHPD cohort.
The NIHPD and the 16p11.2 cohorts show similar proportions in
ancestry composition: Caucasian (>70%), African-american (11% for
NIHPD, 9.38% for 16p11.2), Asian (2% for NIHPD, 1.56% for 16p11.2)
and Other (15% for NIHPD, 10.94% for 16p11.2).
2.2. MRI protocol
The MRI data from the 16p11.2 individuals included T1-weighted
(T1w) anatomical images acquired at 7 sites using different 3T scan-
ners: Philips Achieva, Siemens Prisma Syngo and Siemens Tim Trio. The
MRI protocol included a whole-brain, 3D T1w magnetization prepared
rapid gradient echo sequence (MPRAGE) with 1-mm-thick sagittal slices.
Three sites used multi-echo sequences for 126 participants (38 DEL, 12
DUP, 76 CTRL with 5 familial and 71 unrelated CTRL), and 4 sites used
single-echo sequences for 54 participants (18 DEL, 7 DUP and 29 familial
CTRL). Details of the scanners and image acquisition sequences can be
found in Supplementary Table 2. Extensive analyses on the potential
effect of these scanning sites and protocols were performed in a previous
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deletion or duplication could be attributed to artefacts introduced by the
multisite analyses (Martin-Brevet et al., 2018).
Scans of the NIHPD controls were obtained at 6 study centers with 1.5
Tesla MRI scanners from General Electric or Siemens Medical Systems.
The MRI protocol included a whole-brain, 3D T1w RF-spoiled gradient
echo sequence (1-mm-thick sagittal partitions, TR 22–25 msec, TE 10–11
msec, excitation pulse angle 30, Field Of View 160–180mm). Details on
acquisition and participants were previously published (Evans and Brain
Development Cooperative, 2006).
2.3. Image processing
The longitudinal automatic image processing pipeline, developed for
NIHPD analysis (Aubert-Broche et al., 2013), was adapted to the scans
from the 16p11.2 dataset as described below. The preprocessing steps
applied to the native T1w images were (1) denoising, (2) intensity in-
homogeneity correction using the N3 algorithm (Sled et al., 1998), and
(3) intensity normalization by histogram matching to the ICBM152
template (Fonov et al., 2011). A hierarchical 9-parameter linear regis-
tration based on an intensity cross-correlation similarity measure was
performed between the T1w images and the ICBM152 template to align
the images with the stereotaxic population template (Collins et al., 1994).
Brain extraction was achieved using the Brain Extraction based on
nonlocal Segmentation Technique (BEaST) (Eskildsen et al., 2012), a
multi-resolution, nonlocal patch-based segmentation technique. Subse-
quently, images were non-linearly registered using the Automated
Nonlinear Image Matching and Anatomical Labelling (ANIMAL) algo-
rithm (Collins et al., 1995), a hierarchical, multi-scale registration algo-
rithm. Whole-brain, individual lobes, thalamus, putamen, caudate,
globus pallidus and ventricular volumes were calculated, with the right
and left volumes combined for analysis.
To investigate brain alterations beyond a priori specified anatomical
regions of interest, we used Tensor Based Morphometry (TBM), which
enables a whole-brain voxel-by-voxel statistical analysis while account-
ing for brain size. TBM uses the deformation fields resulting from a non-
linear registration to an appropriate template to analyze group differ-
ences and quantify changes in morphology (Frackowiak, 2004; (Lau
et al., 2008). The non-linear deformation grids for each scan's registration
to the ICBM152 template were inverted, effectively yielding a
voxel-by-voxel nonlinear mapping from the ICBM152 template reference
space to the space of each linearly registered scan. A 3D Gaussian filter
with FWHM of 10mm was applied to the resulting inverted deformation
grids. The Jacobian determinant of the deformation field was computed
for every voxel, log-transformed and used as a surrogate of the local
volume difference between each subject and the ICBM152 template. In
general, a log-transformed Jacobian determinant value less than 0 rep-
resents shrinking from the template to the native space, a value of 0 in-
dicates that there is no volume change in the voxel and a value of more
than 0 indicates enlargement with respect to the template. When Jaco-
bian determinant measures are applied to normative datasets such as the
NIHPD study (Aubert-Broche et al., 2011) Frackowiak, 2004), it enables
the estimation of voxel-wise trajectories of brain development.
2.4. Data analyses
2.4.1. Z-scoring for the main effect of age and gender for global and voxel-
based volumes
To compute Z-scores that normalize for the effect of growth and sex in
a pediatric population, we modeled the effect of those 2 variables in the
NIHPD normative dataset. Mixed-effect models were used since it is
appropriate to estimate growth in longitudinal studies that take repeated
measures from the same individuals over time. It accounts for the within-
participant correlation and for varying numbers of measurements for
each participant.
As we previously described (Aubert-Broche et al., 2013), individual3profiles suggest modeling brain growth as a quadratic function over time:
we included both linear and quadratic effects of age in the fixed effects
structure. Age was not divided into bins, but was considered as a
continuous variable and was centered at 13 years - the mean age of
NIHPD cohort. Linear effect of sex was also included in the fixed terms
(Aubert-Broche et al., 2013). During model selection, a fixed effect for
individual scanner was tested but found to be not significant and the
model was associated with a higher Bayesian Information Criterion
(BIC).
The mixed-effects model that best fits the normative data is:
Voli¼ β0 þ γ0 þ (β1 þ γ1) (Agei-13) þ β2 (Agei-13)2 þ β3 Sexi þ εi
where
 Voli is the value of the response variable (global brain volume or
voxel) for subject i,
 Agei, Age2i, Sexi are the fixed and random effect explanatory variables
for subject i,
 β0, γ0 are the intercept for the fixed and random terms,
 β1, β2, β3 are the fixed effects coefficients and are identical for all
subjects,
 γ1 is a random effect coefficient,
 εi is the error in subject i. The errors for subject i are assumed to have
mean zero and constant independent variance.
Using the mean and the estimated standard deviation of the model we
were able to compute Z-scores for the global volumes of the brain as well
as for each voxel independently, for the 16p11.2 and control participants
using the following formula: z¼(x-x)/s. x is the sample value (i.e. the
volume or Jacobian of an individual subject), x is the estimated mean
from the Mixed Effects model of the NIHPD cohort, and s is an estimate of
the standard deviation, calculated from the variance-covariance matrix
of the fixed effects along with the residual variance of the random effects.
Supplementary Fig. 3 shows the resulting Mixed-Effects fit on Total Brain
Volume for the NIHPD population.
2.4.2. Correcting for scanning protocol between NIHPD normative data and
16p11.2 case-control data
After normalization of the 16p11.2 controls, we observed that certain
regions required small additional corrections attributed to differences in
scanning parameters between the NIHPD and the 16p11.2 data (e.g. 1.5 T
vs 3T scans). We estimated a linear model that included Age and Inter-
cept (i.e. bias and slope) for the Z-scored segmented volumes and the
voxel-wise log-transformed Jacobian determinants of the 16p11.2 con-
trol data. The parameters of this linear model were used to adjust the
16p11.2 control dataset in order to obtain amean Z-score of 0 for all ages.
Supplementary Fig. 4 shows a linear fit of the controls before and after
normalization. The same adjustment was applied to the CNV carrier
groups. This correction shows that there is a simple linear effect of the
scanning protocol. This linear effect is the same between the NIHPD and
16p11.2 control data as well as between the NIHPD and 16p11.2 CNV
carrier data. The intercepts and the slopes were, respectively 0.68/
0.04 for the total brain volume;0.11/0.1 for the gray matter volume
(GM); 0.42/0.05 for the white matter volume (WM) and 0.32/0.02
for the lateral ventricle (LV). Regarding voxel-based mean Z-scores,
16p11.2 CTRL also show deviations from the baseline of NIHPD controls,
in particular in the left putamen and the medial frontal cortex (Z-scores
between 0.88 and 1.09) (Supplementary Figure 5.A).
2.4.3. Analyzing the age-related effects of deletions and duplications on
brain structure
We used a linear model introducing genetic status as a covariate to
investigate the effect of the DEL and DUP on normalized segmented
regional and voxel-level adjusted Z-scores volumes. The following
interaction terms were tested: age*sex and age*group.
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global volumes are Bonferroni corrected for 8 simultaneous comparisons
(4DEL vs CTRL and 4DUP vs CTRL). Results for the voxel-wise
analysis are adjusted using Benjamini-Hochberg False Discovery Rate –
FDR correction (q< 0.05) (Benjamini and Hochberg, 1995). Regions
with significant differences were anatomically labeled using the neuro-
morphometric atlas (http://www.neuromorphometrics.com).
All analyses were conducted using R 3.4.0 (The R Project for Statis-
tical Computing; http://www.R-project.org/). The mixed-effect models
were built using the nlme package.
3. Results
Data was analyzed for 56 DEL, 19 DUP, 105 familial and unrelated
CTRL with ages ranging from 4.5 to 23 years. The clinical phenotype
description of the participants is provided in Table 1.
3.1. Developmental trajectory of total intracranial, global gray and white
matter volumes for deletion and duplication carriers
16p11.2 carriers present an inverse gene dosage effect for most of the
global metrics. Deletion carriers have higher volume than controls for
total brain (mean Z-score¼ 1.165, p-value<0.0001), gray (mean Z-
score¼ 0.414, p-value¼ 0.00433) and white matter volumes (mean Z-
score¼ 0.693, p-value<0.0001) (Fig. 1). Duplication carriers show the
opposite effect, with lower total brain (mean Z-score¼1.17, p-
value¼ 0.0001), gray (mean Z-score¼0.631, p-value¼ 0.00272) and
white matter volume (mean Z-score¼0.53, p-value¼ 0.0018)
compared to controls. Duplication carriers have larger lateral ventricles,
with mean Z-score of 1.629 (p-value<0.0001).
We do not observe any interaction between the effects of genetic
groups and age nor between sex and age. These global brain differences
are unchanged across the full age range in our dataset (Fig. 1).
3.2. Developmental trajectory of regional voxel-based differences
The TBM analysis identifies several brain regions associated with an
inverse gene dosage effect: Deletion carriers have significantly higher
Jacobian determinants than controls, whereas duplication have signifi-
cantly lower values (i.e. DEL> CTRL>DUP) in the following regions:
bilateral calcarine cortex, insula, left transverse temporal gyrus, planum
temporale and parietal operculum. Reciprocal inverse gene dosageFig. 1. Developmental trajectory of global brain metricsTrajectory
of the global brain metrics for the 3 genetic groups show an inverse gene dosage effe
through the development until 23 years of age.
Raw values of each metrics are corrected for age and protocol (i.e. single echo vs mu
centered to 0 for visualization purposes. For each of the genetic groups, fitted lines
represent the confidence interval at each age, the points are normalized subject-level d
in table. P-values are corrected with Bonferroni correction for 8 simultaneous comp
tion carriers.
4effects are also present in the frontal and occipital white matter (Sup-
plemental Table 2, Fig. 2).
Differences predominantly or specifically associated with DEL include
increased Jacobian determinants values in the cuneus, anterior cingulate,
posterior orbital and inferior frontal gyri. Regions predominantly
decreased in DEL compared to controls include the bilateral cerebellum,
middle cingulate gyrus, pallidum, putamen, precentral and post-central
gyri, fusiform gyrus, middle and inferior temporal gyri, supplementary
motor cortex, gyrus rectus, left accumbens area and angular gyrus. The
only region predominantly or specifically associated with DUP is the
occipital fusiform gyrus with a decrease in volume compared to controls
as well as the lateral ventricles that are increased in DUP. Additional
regions with smaller significant clusters are described in Supplemental
Table 2.
We did not identify any effect of age for any of the clusters described
above. Fig. 3 shows this complete lack of age-related effects for the top 8
regional differences with the largest effect sizes. Whatever the age, the
DEL have volume Z-scores of 0.7 and 1 for the anterior insula and the
calcarine cortex respectively, and the DUP have volume Z-scores of 0.9
and 1.2 on the same structures. DEL have volume Z-scores of 0.9 and
0.7 for the posterior orbital and anterior cingulate gyri respectively; they
have the most negative volume Z-scores: 1.6 and 1.1 for the cerebellar
hemispheres and the fusiform gyrus. DUP have also high volume Z-scores
for the lateral ventricle and inferior temporal gyrus, 1.6 and 0.9
respectively.
4. Discussion
The main goal of this study is to identify the onset and potential
changes through childhood, adolescence, and adulthood of brain differ-
ences associated with 16p11.2 CNVs. Our study provides a thorough
investigation of the age-related effects of 16p11.2 deletions and dupli-
cations on brain anatomy between the ages of 4.5 and 23 years. We do
not observe any age-related effects on global and voxel-based volumes in
deletions or duplication carriers. These results are in favor of early onset
of brain changes that remain stable across childhood, adolescence and
early adulthood. Differences related to 16p11.2 CNV carriers are already
present at 5 years of age.
Our method allows us to compute normalized values for neuroana-
tomical regions as well as for each individual voxel despite the fact that
the normative data was acquired on a different scanner. Our results
corroborate global and voxel-based effects described in our previousct, the differences between groups are already present at 4.5 years and identical
lti echo scans) through a linear model, then values from control individuals are
represent the predicted mean computed per age range of 2.4 months, polygons
ata-points. Mean (minimum/maximum of the confidence interval) are presented
arisons (p< 0.05). DEL: deletion carriers; CTRL: control individuals; DUP: duplica-
Fig. 2. Effect of genetic status on brain structures for voxel-based analysesSignificant
differences on Jacobian determinants highlight the inverse gene dosage effect at the regional voxel-based level on volumes between DEL> CTRL>DUP, as well as
some specific volume differences between DEL> CTRL, CTRL>DUP and DEL< CTRL.
A. DEL versus CTRL, B. DUP versus CTRL. Only regions with a FDR correction (q< 0.05) are presented. Negative t-values represent, respectively, the contrasts
DEL< CTRL and DUP< CTRL, positive t-values represent the contrasts DEL> CTRL and DUP> CTRL. DEL: deletion carriers; CTRL: control individuals; DUP: duplica-
tion carriers.
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cortex, temporal and precentral gyri are altered in deletion carriers.
4.1. Continuous model of normative developmental trajectory
The major contribution of our paper is the use of a model to normalize
the non-linear effect of age during typical brain development (Giedd
et al., 1999). This allows us to reliably study a sample of mutation carriers
and controls spanning a broad age range. Papers studying neuroimaging
alterations associated with neurodevelopmental disorders have mostly
used narrow age bins because the study-specific control groups were too
small (less than 100 individuals) to reliably model the effect of age. We
show that despite the fact that the NIHPD data has been collected with a
1.5T magnet, the model for the effect of age during typical brain devel-
opment is robust and applies to data acquired on a 3T after a linear5adjustment. However, integrating large normative datasets to correct for
complex covariates such as age still requires an additional control group
scanned with the same protocol as done here, to be able to match a
particular study to the norm.
4.2. Developmental trajectories in neurodevelopmental disorders and
genetic risk factors
Recently, a large cross-sectional neuroimaging study in idiopathic
ASD (van Rooij et al., 2018) identified differences in subcortical volumes
that are stable across the entire age range of the study from 2 to 64 years
of age. The study also highlighted differences in cortical thickness be-
tween the ASD and control groups. The strongest group differences were
observed during childhood and adolescence, with normalized or even
reversed thickness results in adulthood. However, in the absence of
Fig. 3. Developmental trajectory from typical voxel showing a difference between genetic groupsTrajectory
of the Jacobian determinants of 8 representative voxels from regions with significant differences between genetic groups. All of them are from the right hemisphere.
Anterior insula and calcarine cortex have some voxels with significantly higher values in deletion and lower values in duplication than control individuals. Posterior
orbital gyrus and anterior cingulate gyrus have significantly higher values in deletion carriers compared to controls; on the contrary cerebellum exterior and fusiform
gyrus have significantly lower values in deletion carriers than controls. Lateral ventricle and inferior temporal gyrus have significantly higher values in duplication
carriers than controls. All these differences are already present at 4.5 years and identical through the development until 23 years of age.
Raw values of each voxel are corrected for age and number of echo (i.e. single echo vs multi echo scans) through a linear model, then values from control individuals
are centered to 0 for visualization purposes. For each of the genetic groups, fitted lines represent the predicted mean computed per age range of 2.4 months, polygons
represent the confidence interval at each age, the points are normalized subject-level data-points. Mean (minimum/maximum of the confidence interval) are presented
in the table. DEL: deletion carriers; DUP: duplication carriers. P-values are corrected with an FDR correction, q < 0.05.
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underlying ASD symptoms in participants from these different age
groups. Indeed, ASD diagnostic boundaries have changed tremendously
during the past decade. In contrast, the interpretation of cross-sectional
studies is easier in genetically defined groups since the inclusion
criteria (presence of a specific mutation) does not vary across time,
clinical sites or age of the participants.
Longitudinal studies in idiopathic ASD showed that subcortical al-
terations and increased total and regional cortical surface area present at
2 years of age remain stable at the age of 4 years (Hazlett et al., 2011). An
increase in growth rate of cortical surface area occurs between 6 and 12
months of age and remains stable between 12 and 24 months of age in
high-risk infants who are later diagnosed with ASD compared to low-risk
children (Hazlett et al., 2017). The longitudinal investigation of network
efficiencies also showed that alterations in connectivity of the superior
and middle temporal gyrus as well as the insula are present at 6 and 12
months of age (Lewis et al., 2017).
Few developmental studies in carriers of large genetic risk factors for
ASD or intellectual disability have been conducted. In Fragile X syn-
drome, larger brain volumes are stable between 2 and 5 years of age
(Hazlett et al., 2012). Similar to observations in ASD, neuroimaging
studies of 22q11.2 deletion carriers suggest that alterations in subcortical
and surface area are stable from 5 to 65 years while a few cortical
thickness measures show age-related differences (Sun et al., 2018). They
are the greatest during preadolescence and seem to disappear during6adulthood, although much larger studies are required to confirm this
observation (Schaer et al., 2009).
The main limitations of the present study stem from the technical
differences in acquisition, which include the aforementioned 1.5 T and 3
T fields used in the NIHPD and 16p11.2 datasets respectively. In addition,
the 16p11.2 is a multi-center database, further increasing the variability
in the scans. These acquisition differences can affect the quality of the
non-linear registrations from which the Jacobians are calculated.
Future work should look into improving the current normative
growth curves by further considering additional potential sources of
variation including, but not limited to, ancestry, MRI field strength and
other demographic variables.
The broad age range could have introduced systematic age-dependent
motion artefacts leading to spurious findings. This is however unlikely
due to the absence of any age-related findings in our analysis and the
thorough quality check performed on the dataset.
Our power to observe age-related differences was constrained by
sample size. We estimate that the smallest detectable change with
power¼ 0.80, and alpha¼ 0.05 in the duplication carriers for whole
brain is 0.16 Z-score per year, for gray matter 0.10/year and 0.09/year
for white matter. For deletions, we could detect 0.12 Z-score per year for
whole brain, 0.09/year for gray matter and 0.07/year for white matter.
There is also uncertainty for the lower age range of our study. A larger
sample of younger participants is required to further investigate the
presence of these findings at 4 years of age.
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obesity or severe ASD symptoms that were unable to complete the
scanning session. Nevertheless, our cohort is highly representative of the
Intelligence quotient and psychiatric symptoms observed in our broader
sample of 16p11.2 CNV carriers (D'Angelo et al., 2016).
Future directions to refine the normalization procedure, include
normative data acquired with 3T longitudinal scans and investigations of
other methods such as splines instead of linear mixed models (Mills et al.,
2016).
5. Conclusion
Investigating individuals who carry the same genetic mutation is a
powerful strategy to study alterations of brain growth trajectories asso-
ciated with molecular mechanisms underlying neurodevelopmental dis-
orders. Thanks to a continuous voxel-wise model of normative
developmental trajectory, we show that 16p11.2 CNV carriers have brain
alterations present already at 4.5 years, with comparable effect size from
5 to 20 years of age. The brain differences are reminiscent of MRI studies
in several 16p11.2 deletion mice models which have identified alter-
ations in the insula and striatum at 7 days, equivalent to a prenatal period
in humans (Portmann et al., 2014). Data in neonates and toddlers will be
required to advance our understanding on the onset of these alterations.
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